SecBot SecBot
144 ·Filed Jun 25, 2026

DYN

Dyne Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed4mo ago SEC0001628280-26-045612
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a trivial insider sale proposal by a venture affiliate; the dollar amount is immaterial. No immediate action warranted. Monitor for any large-scale insider selling patterns, but this single filing is not a signal of deterioration.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$20.94
T+0 close · Jun 25, 2026 · via day close
Latest settled
−18.24%
T+60 · $17.12
Vs SPY
−24.35%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 26 $20.94entry
  2. T+1 · 5mo ago +1.53%α −0.12% · $21.26
  3. T+5 · 4mo ago +10.17%α +8.01% · $23.07
  4. T+20 · 4mo ago +14.09%α +12.83% · $23.89
  5. T+60 · 8w ago −18.24%α −24.35% · $17.12
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Atlas Venture Opportunity Fund I, L.P., a venture capital affiliate, filed a Form 144 indicating intent to sell 5,019 shares of Dyne Therapeutics (DYN) common stock, with an estimated value of approximately $102,036. The shares were acquired via private placement in August 2020. The proposed sale is negligible relative to DYN's $3.6B market cap and appears routine portfolio management by a significant early investor.

Key Facts

  • Reporting owner: Atlas Venture Opportunity Fund I, L.P.
  • Proposed sale: 5,019 shares of DYN common stock
  • Estimated market value: $102,036.27 as of June 25, 2026
  • Shares acquired via private placement on August 7, 2020
  • Broker: Merrill Lynch
  • Filing date: June 25, 2026

Financial Impact

Proposed sale of 5,019 shares ($102,036.27), negligible relative to DYN's $3.6B market cap

dilution

Risk Factors

  • Sale may be executed, but volume is too small to affect stock price or liquidity
  • No risk of material dilution or insider sentiment shift from this filing alone

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001628280-26-045612
Document: 0001628280-26-045612-index.html0001628280-26-045612
Document: 0001628280-26-045612.txt0001628280-26-045612

Track record

54 reports on DYN

Performance horizon

12 of 16 bullish or bearish reports moved the stock their way by T+20. Best: +46.36% at T+60 after the May 20, 2026 report. 15 of 16 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G Neutral 3/10 Entry $16.77 Now $16.70 −0.39% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  3. Nov 13, 20263d ago 144 Neutral 2/10 Entry $17.16 Now $16.70 −2.68% settles Dec 15
  4. Nov 5, 202611d ago 8-K Neutral 5/10 No price data
  5. Nov 5, 202611d ago Press Release Neutral 5/10 Entry $17.36 Now $16.70 −3.80% settles Dec 4
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $17.04 Now $16.70 −2.00% settles Nov 27
  7. Oct 22, 202625d ago Press Release Neutral 2/10 Entry $15.62 Now $16.70 +6.91% settles Nov 20
  8. Oct 12, 20265w ago Institutional Cluster Mixed 4/10 Entry $15.96 to $18.62 Now $16.70 +4.64% ▲ +16.67% +19.93% vs SPY
  9. Sep 29, 20266w ago Press Release Bullish 7/10 Entry $16.11 to $16.94 Now $16.70 +3.66% ▲ +5.15% +4.23% vs SPY
  10. Sep 8, 20269w ago Insider Cluster Neutral 3/10 Entry $19.19 to $15.97 Now $16.70 −12.98% ▼ −16.78% −18.72% vs SPY
Showing 10 of 54

US Market Status

Market Closed · Opens Wed (9h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 3, 2026